LKT Labs

Biochemicals for Life Science Research

HIV Protease Substrate ARVLAEA

HIV Protease Substrate ARVLAEA

Product ID H3276
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $245.00 Please Inquire
Bulk Quote

Quicklinks

Description

HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.

Product Info

Purity

≥98%
Formula

C33H59N11O10
Formula Wt.

769.90
Solubility

Soluble in water (2 mg/mL), acetonitrile.

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

Info Sheet

H3276 Info Sheet PDF

References

Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A971334

    Azilsartan

    Sartan

    ≥98%
  • L8261

    Lupeol

    Triterpene; potential tyrosinase inhibitor.

    ≥98%
  • T5869

    Torcetrapib

    Cholesterol ester transfer protein inhibitor.

    ≥98%
  • E9317

    Exemestane

    Aromatase inhibitor.

    ≥97%
  • D3330

    Dihydrotanshinone

    Found in Salvia; fatty acid synthase and AChE i...

    ≥90%
  • P3600

    PJ34 Hydrochloride

    PARP inhibitor; potential Pim1 inhibitor.

    ≥95%
  • D490280

    DMH-1

    Inhibitor of BMP.

    ≥99%
  • C0265

    Carnosic Acid

    Diterpene found in Rosmarinus.

    ≥98%
  • P3440

    PIK-293

    p110δ PI3K inhibitor.

    ≥98%
  • S8007

    Substance P (1-7)

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • B1874

    Bestatin Hydrochloride

    Dipeptide; aminopeptidase (N/CD13) inhibitor.

    ≥98%
  • V3325

    Virginiamycin M1

    Macrolide antibiotic; peptidyl transferase inhi...

    ≥97%
  • A0534

    Abiraterone

    Progesterone derivative; Cyp17A1 inhibitor.

    ≥99%
  • R8122

    Rufloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • C9610

    D-Cycloserine

    NMDA partial agonist, D-Ala-D-Ala ligase inhibi...

    ≥98%
  • L0254

    Lansoprazole

    H+/K+ ATPase inhibitor.

    ≥98%
  • C0262

    L-Carnitine

    Endogenous quaternary ammonium, required for fa...

    ≥98%
  • A7657

    Atosiban Acetate

    Peptide, alters uterine contractility; V1/2 and...

    ≥95%
  • P6818

    Prednisolone

    Cortisol derivative; glucocorticoid agonist.

    ≥98%
  • C4556

    Clofibric Acid

    Metabolite of clofibrate; PPARα agonist.

    ≥98%